Collegium Pharmaceutical
COLL
COLL
241 hedge funds and large institutions have $1.1B invested in Collegium Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 98 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
+3
Holders Change %
+1.26%
% of All Funds
3.27%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
33
Increased
76
Reduced
98
Closed
25
Calls
$617K
Puts
$184K
Net Calls
+$433K
Net Calls Change
+$3K
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$19.4M |
| 2 |
Millennium Management
New York
|
+$13.8M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$10.9M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$5.59M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.69M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$51.4M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$4.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$4.28M |
| 4 |
Man Group
London,
United Kingdom
|
-$3.39M |
| 5 |
BlackRock
New York
|
-$3.02M |
